{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:54:28Z","timestamp":1792803268720,"version":"4.5.0"},"reference-count":29,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101007873"],"award-info":[{"award-number":["101007873"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1183\/13993003.01531-2025","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:50:13Z","timestamp":1773935413000},"page":"2501531","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rising bedaquiline resistance: exploring potential causes and next steps"],"prefix":"10.1183","volume":"67","author":[{"given":"Jodie A.","family":"Schildkraut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-5449","authenticated-orcid":false,"given":"Derek J.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-4741","authenticated-orcid":false,"given":"Christoph","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"2026052103351241000_67.5.2501531.1","unstructured":"World Health Organization . Global Tuberculosis Report 2024. Geneva, World Health Organization, 2024."},{"key":"2026052103351241000_67.5.2501531.2","unstructured":"World Health Organization . Key Updates to the Treatment of Drug Resistant Tuberculosis: Rapid Communication, June 2024. Geneva, World Health Organization, 2024."},{"key":"2026052103351241000_67.5.2501531.3","doi-asserted-by":"crossref","first-page":"e0296448","DOI":"10.1371\/journal.pone.0296448","article-title":"Global adoption of 6-month drug-resistant TB regimens: projected uptake by 2026","volume":"19","author":"Gupta","year":"2024","journal-title":"PLoS ONE"},{"key":"2026052103351241000_67.5.2501531.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31644-1"},{"key":"2026052103351241000_67.5.2501531.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00639-2023"},{"key":"2026052103351241000_67.5.2501531.6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/cid\/ciad684","article-title":"Monitoring of first-line drug resistance mutations outside the scope of Xpert MTB\/RIF Ultra is needed for successful control of DR-TB in southern mozambique","volume":"78","author":"Mariner-Llicer","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026052103351241000_67.5.2501531.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00621-2021"},{"key":"2026052103351241000_67.5.2501531.8","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1016\/S2666-5247(23)00172-6","article-title":"Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study","volume":"4","author":"Derendinger","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026052103351241000_67.5.2501531.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-051521"},{"key":"2026052103351241000_67.5.2501531.10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1186\/s12879-022-07861-x","article-title":"Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis","volume":"22","author":"Pai","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026052103351241000_67.5.2501531.11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3201\/eid2905.221716","article-title":"Therapeutic failure and acquired bedaquiline and delamanid resistance in treatment of drug-resistant TB","volume":"29","author":"Millard","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2026052103351241000_67.5.2501531.12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5588\/ijtld.24.0610","article-title":"Model-based evaluation of adherence to bedaquiline and clofazimine in adults with drug-resistant TB","volume":"29","author":"Resendiz-Galvan","year":"2025","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026052103351241000_67.5.2501531.13","first-page":"1","article-title":"The impact of first-line anti-tubercular drugs\u2019 pharmacokinetics on treatment outcome: a systematic review","volume":"13","author":"Sileshi","year":"2021","journal-title":"Clin Pharmacol"},{"key":"2026052103351241000_67.5.2501531.14","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2016.1200462"},{"key":"2026052103351241000_67.5.2501531.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00498-X"},{"key":"2026052103351241000_67.5.2501531.16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02418-20"},{"key":"2026052103351241000_67.5.2501531.17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00426-5"},{"key":"2026052103351241000_67.5.2501531.18","unstructured":"World Health Organization . Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines used in the Treatment of Drug-resistant Tuberculosis. Geneva, World Health Organization, 2018."},{"key":"2026052103351241000_67.5.2501531.19","unstructured":"World Health Organization . Catalogue of Mutations in Mycobacterium tuberculosis Complex and their Association with Drug Resistance, Second Edition. Geneva, World Health Organization, 2023."},{"key":"2026052103351241000_67.5.2501531.20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/antibiotics9030133","article-title":"Whole genome sequencing for the analysis of drug resistant strains of mycobacterium tuberculosis: a systematic review for bedaquiline and delamanid","volume":"9","author":"Nieto Ramirez","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2026052103351241000_67.5.2501531.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00391-2024"},{"key":"2026052103351241000_67.5.2501531.22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-2600(25)00246-2","article-title":"endTB-Q results in the face of rising bedaquiline resistance","volume":"13","author":"Heinrich","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026052103351241000_67.5.2501531.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.02.027"},{"key":"2026052103351241000_67.5.2501531.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510010071032"},{"key":"2026052103351241000_67.5.2501531.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00199814"},{"key":"2026052103351241000_67.5.2501531.26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/cid\/ciaf068","article-title":"Bedaquiline resistance and treatment outcomes among patients with tuberculosis previously exposed to bedaquiline in India: a multicentric retrospective cohort study","volume":"81","author":"Singla","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026052103351241000_67.5.2501531.27","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00218-X"},{"key":"2026052103351241000_67.5.2501531.28","doi-asserted-by":"crossref","first-page":"e0183924","DOI":"10.1128\/aac.01839-24","article-title":"Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia","volume":"69","author":"Ardizzoni","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026052103351241000_67.5.2501531.29","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.lanepe.2025.101380","article-title":"Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study","volume":"56","author":"Kherabi","year":"2025","journal-title":"Lancet Reg Health Eur"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01531-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:35:22Z","timestamp":1779359722000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01531-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,21]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1183\/13993003.01531-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01531-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}